Literature DB >> 23348620

A novel adipokine C1q/TNF-related protein 1 (CTRP1) regulates chondrocyte proliferation and maturation through the ERK1/2 signaling pathway.

Hironori Akiyama1, Masataka Otani, Sunao Sato, Satoru Toyosawa, Souhei Furukawa, Satoshi Wakisaka, Takashi Maeda.   

Abstract

Adipose tissue-derived adipokines play important roles as regulators of skeletal growth and development. CTRP1, a paralog of adiponectin, is a member of the C1q and tumor necrosis factor (TNF)-related protein (CTRP) superfamily. It is expressed at high levels in adipose tissue and has recently emerged as a novel adipokine. In the present study, we provide the first evidence for a physiological role of the CTRP1 in chondrocyte proliferation and maturation using a mouse chondrocytic cell line, N1511. The CTRP1 protein was strongly expressed and predominantly distributed in the reserve and proliferative chondrocytes in the fetal growth plate and its mRNA decreased during the maturation of N1511 chondrocytes. Recombinant CTRP1 promoted proliferation of immature proliferating N1511 chondrocytes in a dose-dependent manner, whereas it inhibited maturation of maturing N1511 chondrocytes. The stimulatory effect of CTRP1 on chondrocyte proliferation was associated with activation of the extracellular signal-regulated kinases 1/2 (ERK1/2) signaling pathway. On the other hand, the inhibitory effect of CTRP1 on chondrocyte maturation is associated with suppression of the ERK1/2 pathway. These results suggest a novel physiological role for CTRP1 in endochondral ossification.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348620     DOI: 10.1016/j.mce.2013.01.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  A novel adipokine C1q/TNF-related protein 3 is expressed in developing skeletal muscle and controls myoblast proliferation and differentiation.

Authors:  Masataka Otani; Souhei Furukawa; Satoshi Wakisaka; Takashi Maeda
Journal:  Mol Cell Biochem       Date:  2015-08-14       Impact factor: 3.396

2.  CTRP1 Attenuates UUO-induced Renal Fibrosis via AMPK/NOX4 Pathway in Mice.

Authors:  Wen Li; Fan Cheng; Yi-Yan Songyang; Song-Yi-Sha Yang; Jie Wei; Yuan Ruan
Journal:  Curr Med Sci       Date:  2020-03-13

3.  C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells.

Authors:  Dough Kim; Seung-Yoon Park
Journal:  Genes Genomics       Date:  2018-11-24       Impact factor: 1.839

Review 4.  CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication.

Authors:  Huan Zhang; Zi-Yin Zhang-Sun; Cheng-Xu Xue; Xi-Yang Li; Jun Ren; Yu-Ting Jiang; Tong Liu; Hai-Rong Yao; Juan Zhang; Tian-Tian Gou; Ye Tian; Wang-Rui Lei; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2022-10-07       Impact factor: 7.169

5.  CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.

Authors:  Zheyi Yan; Jianli Zhao; Lu Gan; Yanqing Zhang; Rui Guo; Xiaoming Cao; Wayne Bond Lau; Xin Ma; Yajing Wang
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

6.  Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.

Authors:  Liyan Chen; Gang Su
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

7.  Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway.

Authors:  Jing Hui; Qi Lei; Zhi Ji; Dingjing Zi
Journal:  Biol Res       Date:  2022-04-04       Impact factor: 5.612

8.  Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21.

Authors:  Sora Han; Jong Dai Kim; Sunyi Lee; Ae Lee Jeong; Jeong Su Park; Hyo Jeong Yong; Ariundavaa Boldbaatar; Hye In Ka; Eun-Jung Rhee; Won-Young Lee; Young Yang
Journal:  Int J Endocrinol       Date:  2016-05-23       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.